Puzzle Medical Devices Inc., a Montreal-based medtech startup focusing efforts on patients suffering from heart failure, is thrilled to announce the closing of its first convertible debenture financing round led by Canadian entrepreneur Pascal Labrecque.
Other participants include a United States venture capital firm, entrepreneurs and interventional cardiologists practicing in Canada, the United States and Europe. This investment follows the successful completion of Puzzle Medical's first preclinical studies and will support the continued development towards clinical testing of a revolutionary transcatheter pump intended for chronic support.
"This technology clearly answers an unmet need in the management of chronic heart failure patients," said Philippe Généreux, MD, Interventional Cardiologist at Morristown Medical Center, New Jersey, USA. "I have been extremely impressed by the success achieved during the initial preclinical work and remain excited and confident about its future application in patients."
To read the complete press release :